Angiogenesis Inhibitors in NSCLC

Angiogenesis is a complex biological process that plays a relevant role in sustaining the microenvironment, growth, and metastatic potential of several tumors, including non-small cell lung cancer (NSCLC). Bevacizumab was the first angiogenesis inhibitor approved for the treatment of patients with a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Manzo, Anna, Montanino, Agnese, Carillio, Guido, Costanzo, Raffaele, Sandomenico, Claudia, Normanno, Nicola, Piccirillo, Maria Carmela, Daniele, Gennaro, Perrone, Francesco, Rocco, Gaetano, Morabito, Alessandro
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666703/
https://ncbi.nlm.nih.gov/pubmed/28934120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18102021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados